When COVID-19 first emerged, the U.S., under President Donald Trump, made an urgent bet on vaccines — and it paid off ...

Measles could be well positioned for a comeback in the United States in a very short period of time. If immunization rates ...

Concerned that the nation’s health leadership is casting unfounded doubt on the safety of well-studied vaccines and may take ...

The Centers for Disease Control and Prevention might soon limit its guidance for who should receive a coronavirus booster ...

Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...

The global bioanalytical testing services market was worth USD 2.7 billion in 2020 and is further projected to reach USD 6.1 billion by 2027, at a CAGR of 12.1% during the forecast period (2021-2027).

SHELTON, CT / ACCESS Newswire / April 14, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a leading global pioneer in the development of broad-spectrum ant ...

Kim Witczak has crusaded for informed consent in antidepressants for two decades and more recently joined with Marty Makary, ...

While Kennedy may now publicly acknowledge vaccine efficacy out of political calculation ... patient areas claiming to be looking for “COVID bags” supposedly placed over patient heads.

An electronic registry would replace the yellow paper immunization cards that Ontarians now use to track their vaccinations.

are a result of scientific review to ensure safety and efficacy," an HHS official familiar with the situation told Reuters. The Maryland-based company's protein-based COVID-19 vaccine offers an ...

are a result of scientific review to ensure safety and efficacy," an HHS official familiar with the situation told Reuters. The Maryland-based company's protein-based COVID-19 vaccine offers an ...